Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Loyalty card data could help to identify ovarian cancer symptoms sooner
Loyalty card data on over-the-counter medicine purchases could help spot ovarian cancer cases earlier according…
New biomarker strategy devised to screen for, diagnose deadly heart complication from cancer treatment
Researchers have devised a new biomarker-based strategy to screen for a rare and deadly complication…
Epigenetics breaks into the clinical practice of cancer
In the early 1980s, the first changes in DNA related to a chemical modification called…
Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer
- When to stop screening? Strategy for increasing shared decision-making by physicians and older patients about colorectal cancer screening
- Strategic research and development collaboration in RAS/MAPK-driven cancers announced
- Can exercise boost chemotherapy’s effectiveness, improve outlook for colon cancer survivors?
Cutting cancer costs is a worthy policy, but we need to try to prevent it too
Terry Slevin, Australian National University and Simone Pettigrew, Curtin University Removing the financial worries from Australians diagnosed with cancer is…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.